Chris has given you good advice. I would say that you need to ask your doctor if he/she is reporting your PCR results according to the IS(international scale)...depending on where you're are being treated I suspect not. You might be able to ask for the labs conversion factor so that you can convert the 0.7% result(your latest one and in my view not significantly different from the previous on at 0.6%) to tally with the IS.
For example:
In order to convert a given local labs qRT-PCR result to the international scale, it is necessary to calculate a conversion factor (CF)for that lab, which can be done as follows:
Given that 0.1% is agreed as MMR (or 3 log reduction) on the international scale (IS)
To find a local lab's Conversion Factor you need to divide 0.1%(MMR IS) by MMREq (whatever MMR value is at the local lab)
Once calculated it can be used to convert all that particular labs qRT_PCR results to the International Scale.
However, even if the lab has already calculated a conversion factor, not all doctors report PCR results on the IS to their patients. You will need to discuss this with your doctor.
From what you say, you are responding very well to nilotinib (Tasigna) after reaching a response 'plateau' on imatinib (Glivec). As Chris has already said, your doctor was right to change your therapy to a second generation TKI.... and it is obvious that the side effects are much less for you.
Your goal for now would be to get down to MMR (0.1% IS). When you reach this, then you can start to think about getting lower- some do, but a lot of patients do not or they take a long time to get down any further - as Chris says, this is a marathon not a sprint.
I hope this has not confused you further. Best to ask your doctor about how your PCR results are currently reported... IS or Local value?
Remember also that any given blood or marrow sample must contain an adequate number of control gene transcripts if you are to get a significant result. To report MMR there must be at least 10,000 control gene transcripts (ie. normal genes such as ABL or BCR)this way they can calculate the ratio of normal to abnormal (BCR-ABL1)transcripts in a sample.
Best wishes,
Sandy